GSK facing months of industrial action as workers go on strike at pharma giant Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments. Daily Record · Jan 9, 2023
GSK to move back to central London with new HQ Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO Evening Standard · Dec 12, 2022
Moonpig flotation price, like so many, was always pie-in-the-sky thinking You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses The Guardian - UK · Dec 7, 2022
GSK shares surge as US judge dismisses Zantac cancer claims About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer The Guardian - UK · Dec 7, 2022
AstraZeneca looks fighting fit despite the ills of the UK science sector Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week The Guardian - UK · Nov 6, 2022
Mark Zuckerberg’s metaverse is a joke not shared by investors Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course The Guardian - UK · Nov 2, 2022
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02 Reuters Benzinga · Nov 2, 2022
Strong RSV vaccine data lifts hopes after years of futility A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV The Independent UK · Nov 1, 2022
Gareth Thomas thanks ViiV for support in fight against HIV stigma Gareth Thomas visited GSK House in his latest stop on the Myth Bus Tour. Wales Online · Oct 31, 2022
‘A better partner’: Labour woos big business in bid to oust Rishi Sunak Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election The Guardian - UK · Oct 28, 2022
3 Upgraded Stocks to Consider Buying This Week The red-hot inflation is increasing the odds of continued rate hikes by the Fed. Since the market is expected to remain under pressure on recession fears, it could be wise to invest in fundamentally sound stocks Comcast Corporation (CMCSA), GSK (GSK), and Masonite International (DOOR), which have been recently upgraded… StockNews.com · Oct 17, 2022
GSK vaccine shows ‘exceptional’ efficacy against common lung infection RSV The pharmaceutical giant’s vaccine was found to be 82.6 per cent effective in Phase III clinical trials Evening Standard · Oct 14, 2022
Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13 Reuters Benzinga · Oct 13, 2022
Pollen does more than make you sneeze. It can cause thunderstorm asthma, even if you're not asthmatic Climate change has caused melting icebergs, flooding, and landslides. It can also bring about an increase in pollen levels, prolong the duration of pollen season, and cause more pollen-related health problems. The Conversation · Oct 5, 2022
Wales Online · Sep 30, 2022 Eamonn Holmes shares details of 'ghastly' health scare Television presenter calls for more awareness and understanding to fight the illness
Daily Mirror · Sep 30, 2022 Questions you should ask your GP if you're concerned about your periods and gynae problems Research shows one in four people have felt not listened to in a gynae health appointment - checklist shows how you can prepare for GP appointments so it feels less daunting
Benzinga · Sep 26, 2022 iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26 Bloomberg
Benzinga · Sep 22, 2022 Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
The Guardian - UK · Sep 20, 2022 The only party not getting heartburn over GSK demerger is the lawyers The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years
Evening Standard · Sep 20, 2022 Sensodyne maker Haleon sees 22% profit rise in first results since GSK demerger Haleon demerged from its parent company in July
StockNews.com · Sep 13, 2022 5 “Strong Buy” Health Care Stocks to Buy This Week Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…
StockNews.com · Sep 12, 2022 3 Health Care Stock Under $50 You Can Buy Today The healthcare industry is anticipated to grow significantly in the coming years, thanks to strong demand amid rising chronic diseases, technological advancements, and rising healthcare spending. Therefore, we think fundamentally sound healthcare companies Pfizer (PFE), GSK Plc (GSK), and Teva Pharmaceutical (TEVA), which are currently trading under $50, could be…
The Conversation · Sep 6, 2022 How should New Zealand manage COVID from now – limit all infections or focus on preventing severe disease? As the New Zealand government reviews mask mandates and other pandemic measures this week, we argue it’s time to reconsider the overall COVID strategy.
The Independent UK · Sep 5, 2022 Chemical engineer fired by pharma giant GlaxoSmithKline after racist, homophobic rant on plane Man mentioned employer GlaxoSmithKline in rant, calling it ‘one of the best f***ing companies in the world’
Benzinga · Aug 11, 2022 Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar